Evidence map›Paper›PMID 18559542›Full record

ArticleCancer research2008

Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions.

Susan R Mallery, Jared C Zwick, Ping Pei, Meng Tong, Peter E Larsen, Brian S Shumway, Bo Lu, Henry W Fields, Russell J Mumper, Gary D Stoner

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01192204 (Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention), which is not on this map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01192204 phase1 / phase2completednot on this mapstarted 2010, after this paper: background citation

Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention

TypeinterventionalSponsorOhio State UniversityRan2010 to 2014Enrolled41ConditionsSquamous Cell Carcinoma of Mouth, Intraepithelial NeoplasiaArms10% FBR containing bioadhesive gel, placebo gel
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Oral Health and Nutraceutical Agents.International journal of molecular sciences · 2024
    Review
  11. Berries vs. Disease: Revenge of the Phytochemicals.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Susan R MalleryDepartment of Oral and Maxillofacial Surgery, College of Dentistry, The Ohio State University Comprehensive Cancer Center and Solove Research Institute, Columbus, Ohio, USA. mallery.1@osu.edu
Jared C Zwick
Ping Pei
Meng Tong
Peter E Larsen
Brian S Shumway
Bo Lu
Henry W Fields
Russell J Mumper
Gary D Stoner
National Medical Research Center of Dentistry and Maxillofacial Surgery · RUThe Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · USUniversity of Louisville Hospital · USUniversity of North Carolina at Chapel Hill · US

Funding

Chemoprevention of Oral Dysplasia by Black RaspberriesR21CA111210 · NCI · OHIO STATE UNIVERSITY · PI MALLERY, SUSAN R · 2004 to 2005
$404k
NCI NIH HHS R21 CA111210
6 · The paper itself

Abstract

Reduced expression of proapoptotic and terminal differentiation genes in conjunction with increased levels of the proinflammatory and angiogenesis-inducing enzymes, cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS), correlate with malignant transformation of oral intraepithelial neoplasia (IEN). Accordingly, this study investigated the effects of a 10% (w/w) freeze-dried black raspberry gel on oral IEN histopathology, gene expression profiles, intraepithelial COX-2 and iNOS proteins, and microvascular densities. Our laboratories have shown that freeze-dried black raspberries possess antioxidant properties and also induce keratinocyte apoptosis and terminal differentiation. Oral IEN tissues were hemisected to provide samples for pretreatment diagnoses and establish baseline biochemical and molecular variables. Treatment of the remaining lesional tissue (0.5 g gel applied four times daily for 6 weeks) began 1 week after the initial biopsy. RNA was isolated from snap-frozen IEN lesions for microarray analyses, followed by quantitative reverse transcription-PCR validation. Additional epithelial gene-specific quantitative reverse transcription-PCR analyses facilitated the assessment of target tissue treatment effects. Surface epithelial COX-2 and iNOS protein levels and microvascular densities were determined by image analysis quantified immunohistochemistry. Topical berry gel application uniformly suppressed genes associated with RNA processing, growth factor recycling, and inhibition of apoptosis. Although the majority of participants showed posttreatment decreases in epithelial iNOS and COX-2 proteins, only COX-2 reductions were statistically significant. These data show that berry gel application modulated oral IEN gene expression profiles, ultimately reducing epithelial COX-2 protein. In a patient subset, berry gel application also reduced vascular densities in the superficial connective tissues and induced genes associated with keratinocyte terminal differentiation.

Indexed as

FruitPhytotherapyAdministration, TopicalAdultAgedBlotting, WesternCarcinoma in SituCarcinoma, Squamous CellCyclooxygenase 2FemaleGelsHumansMaleMiddle AgedMouth NeoplasmsNeoplasm InvasivenessCyclooxygenase 2GelsNitric Oxide Synthase Type IINOS2 protein, humanPTGS2 protein, human

Identifiers

PMID18559542
PMCPMC2892791
OpenAlexW2156631697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.